A low molecular weight copper chelator crosses the blood–brain barrier and attenuates experimental autoimmune encephalomyelitis von Offen, Daniel, Gilgun‐Sherki, Yossi, Barhum, Yael, Benhar, Moran, Grinberg, Leonid, Reich, Reuven, Melamed, Eldad, Atlas, Daphne

Volltext

The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy von GILGUN-SHERKI, Yossi, MELAMED, Eldad, OFFEN, Daniel

Volltext

Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections... von Cohen-Barak, Orit, Wildeman, Jacqueline, van de Wetering, Jeroen, Hettinga, Judith, Schuilenga-Hut, Petra, Gross, Aviva, Clark, Shane, Bassan, Merav, Gilgun-Sherki, Yossi, Mendzelevski, Boaz, Spiegelstein, Ofer

Volltext

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands von Fleseriu, Maria, Molitch, Mark, Dreval, Alexander, Biermasz, Nienke R, Gordon, Murray B, Crosby, Ross D, Ludlam, William H, Haviv, Asi, Gilgun-Sherki, Yossi, Mathias, Susan D

Volltext

Central nervous system effects of the histamine‐3 receptor antagonist CEP‐26401, in comparison with modafinil and donepezil, after a single dose in a cross‐over study in healthy vo... von Baakman, Anne C., Zuiker, Rob, Gerven, Joop M.A., Gross, Nicholas, Yang, Ronghua, Fetell, Michael, Gershon, Ari, Gilgun‐Sherki, Yossi, Hellriegel, Edward, Spiegelstein, Ofer

Volltext

Antioxidant treatment in Alzheimer's disease: current state von Gilgun-Sherki, Yossi, Melamed, Eldad, Offen, Daniel

Volltext

A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease von Bahat-Stroomza, Merav, Gilgun-Sherki, Yossi, Offen, Daniel, Panet, Hana, Saada, Ann, Krool-Galron, Nili, Barzilai, Aari, Atlas, Daphne, Melamed, Eldad

Volltext

Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis von Gilgun-Sherki, Yossi, Panet, Hana, Holdengreber, Vered, Mosberg-Galili, Ronit, Offen, Daniel

Volltext

MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly von Fleseriu, Maria, Molitch, Mark, Dreval, Alexander, Pokramovich, Yulia, Bondar, Irina, Poteshkin, Yury, Macut, Djuro, Obermayer-Pietsch, Barbara, Gilgun-Sherki, Yossi, Haviv, Asi, Biermasz, Nienke, Strasburger, Christian J

Volltext

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier von Gilgun-Sherki, Yossi, Melamed, Eldad, Offen, Daniel

Volltext

Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate von Ziemssen, Tjalf, Gilgun-Sherki, Yossi

Volltext

Multimodality assessment of hepatic fibrosis: ranked paired reading and artificial intelligence identifies fibrosis improvement with aramchol missed by conventional staging von Ratziu, Vlad, Yılmaz, Yusuf, Lazas, Don, Friedman, Scott, Lackner, Carolin, Behling, Cynthia, Cummings, Oscar, Chen, Li, Petitjean, Mathieu, Gilgun-Sherki, Yossi, Kadosh, Shaul, Sanyal, Arun

Volltext

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial von Fleseriu, Maria, Dreval, Alexander, Bondar, Irina, Vagapova, Gulnar, Macut, Djuro, Pokramovich, Yulia G, Molitch, Mark E, Leonova, Nina, Raverot, Gerald, Grineva, Elena, Poteshkin, Yury E, Gilgun-Sherki, Yossi, Ludlam, William H, Patou, Gary, Haviv, Asi, Gordon, Murray B, Biermasz, Nienke R, Melmed, Shlomo, Strasburger, Christian J

Volltext

Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence von Gilgun-Sherki, Yossi, Eliaz, Rom E, McCann, David J, Loupe, Pippa S, Eyal, Eli, Blatt, Kathleen, Cohen-Barak, Orit, Hallak, Hussein, Chiang, Nora, Gyaw, Shwe

Volltext

Abstract #1041607: Effects of Prior Injectable Somatostatin Receptor Ligand Type and Dose in Patients With Acromegaly Receiving Oral Octreotide Capsules in the Phase 3 MPOWERED Tri... von Gordon, Murray B., Fleseriu, Maria, Biermasz, Nienke, Dreval, Alexander, Pokramovich, Yulia G., Bondar, Irina, Isaeva, Elena, Molitch, Mark E., Macut, Djuro P., Gilgun-Sherki, Yossi, Ludlam, William H., Patou, Gary, Haviv, Asi, Strasburger, Christian J., Melmed, Shlomo

Volltext

Abstract #1041639: Improved Quality of Life and Work Productivity in Patients With Acromegaly Receiving Oral Octreotide Capsules in the Phase 3 MPOWERED Trial von Biermasz, Nienke, Fleseriu, Maria, Gordon, Murray B., Dreval, Alexander, Pokramovich, Yulia G., Bondar, Irina, Isaeva, Elena, Molitch, Mark E., Macut, Djuro P., Gilgun-Sherki, Yossi, Ludlam, William H., Patou, Gary, Haviv, Asi, Strasburger, Christian J., Melmed, Shlomo

Volltext

Abstract #1000028: Injection Site Reactions and Their Impact in Patients With Acromegaly Receiving Injectable Somatostatin Receptor Ligands in the Phase 3 MPOWERED Trial von Gordon, Murray B., Fleseriu, Maria, Bondar, Irina, Isaeva, Elena, Molitch, Mark E., Macut, Djuro P., Leonova, Nina, Raverot, Gerald, Gilgun-Sherki, Yossi, Ludlam, William H., Patou, Gary, Haviv, Asi, Biermasz, Nienke, Melmed, Shlomo, Strasburger, Christian J.

Volltext

Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis von Gilgun-Sherki, Yossi, Panet, Hana, Melamed, Eldad, Offen, Daniel

Volltext

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial von Ziemssen, Tjalf, Bajenaru, Ovidiu A., Carrá, Adriana, de Klippel, Nina, de Sá, João C., Edland, Astrid, Frederiksen, Jette L., Heinzlef, Olivier, Karageorgiou, Klimentini E., Lander Delgado, Rafael H., Landtblom, Anne-Marie, Macías Islas, Miguel A., Tubridy, Niall, Gilgun-Sherki, Yossi

Volltext

RF13 | PMON159 Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly: MPOWERED Trial Open-Label Extension Phase von Fleseriu, Maria, Molitch, Mark E, Dreval, Alexander, Pokramovich, Yulia G, Bondar, Irina, Poteshkin, Yury E, Macut, Djuro P, Obermayer-Pietsch, Barbara, Gilgun-Sherki, Yossi, Haviv, Asi, Biermasz, Nienke, Melmed, Shlomo, Strasburger, Christian J

Volltext